+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Virtual Clinical Trials Market Size, Share & Trends Analysis Report By Study Design (Interventional, Observational, Expanded Access), By Indication (Oncology, Cardiovascular Disease), By Phase, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 133 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5415490
Description Jump to:
The global virtual clinical trials market size is expected to reach USD 12.9 billion by 2030. The market is expected to expand at a CAGR of 5.7% from 2023 to 2030. The COVID-19 pandemic has significantly impacted the market. The growing need for patient diversity clubbed with enhanced data collection in clinical trials is boosting the market growth.

There has been a rise in the R&D of new drugs and vaccines that has increased the volume and complexity of clinical trials. Virtual clinical trials eliminate challenges posed by traditional clinical trials for example delays in patient recruitment and time-consuming procedures. Also, studies have revealed that around 75.0% of people favored a mobile trial over traditional ones and 80.0% of patients are more likely to participate in a clinical trial that uses mobile technology.

The market is recovering at a significant pace after the pandemic as it offers various benefits to patients as well as sponsors. During the pandemic, traveling was potentially dangerous. It can be expensive, even incurring lost wages or requiring that childcare/eldercare be hired. These drawbacks limit initial interest and provide a simple solution for virtual clinical trials. Virtual clinical trials offer various benefits such as effective data collection, analysis, and monitoring of large amounts of data in real-time.

Virtual trials make use of monitoring devices, software apps, and online social engagement platforms to conduct every step of the clinical trial process including patient recruitment, counseling, measuring clinical endpoints, informed consent, and adverse reactions. Telehealth, home care, and remote patient monitoring have been gaining momentum as a healthcare offering, and COVID-19 is adding more horsepower to this initiative.

However, the healthcare system is impacted by geopolitical conflicts across the globe, such as the military conflict in Ukraine and Eastern Europe. The clinical trials in Ukraine and neighboring parts of Eastern Europe were under threat due to the conflicts. For instance, according to FDA, 251 devices and drugs were under clinical trials in Ukraine, but the conflict led many pharmaceuticals to put the initiation of a new trial on hold and pause patient recruitment efforts in existing trials. Thus, increasing geopolitical issues in Europe are expected to hinder the virtual clinical trials market in the region.

Virtual Clinical Trials Market Report Highlights

  • The oncology segment held 25.2% of the revenue share in 2022. The increasing adoption of virtual trials especially in oncology clinical research for diverse populations is responsible for the growth of the segment
  • The interventional design segment accounted for the largest revenue share of 46.7% in 2022
  • North America held 49.0% of the revenue share in 2022. Favorable government initiatives and the presence of large numbers of players in the U.S. offerings advanced services are responsible for market growth
  • In Asia Pacific, the market is expected to witness the fastest CAGR of 6.8% over the forecast period owing to the increasing patient pool and cost-efficient services


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. COUNTRY MARKET: CAGR CALCULATION
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Virtual Clinical Trials Market Snapshot
2.6. Virtual Clinical Trials Market Segment Snapshot
2.7. Virtual Clinical Trials Market Competitive Landscape Snapshot
Chapter 3. Virtual Clinical Trials Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. The growing role of technology in the healthcare
3.2.1.2. Benefits of virtual trials
3.2.1.3. Government support
3.2.2. Market Restraint Analysis
3.2.2.1. Data security
3.2.3. Market Challenge Analysis
3.3. Virtual Clinical Trials Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.3. COVID-19 pandemic impact on clinical trial activity
Chapter 4. Virtual Clinical Trials Market: Study Design Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Virtual Clinical Trials Market: Study Design Movement Analysis, USD Million, 2022 & 2030
4.3. Interventional
4.3.1. Interventional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Observational
4.4.1. Observational Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Expand Access
4.5.1. Expand Access Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Virtual Clinical Trials Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Virtual Clinical Trials Market: Indication Movement Analysis, USD Million, 2022 & 2030
5.3. CNS
5.3.1. CNS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Autoimmune/Inflammation
5.4.1. Autoimmune/Inflammation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular Disease
5.5.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Metabolic/Endocrinology
5.6.1. Metabolic/Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Infectious Disease
5.7.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Oncology
5.8.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Genitourinary
5.9.1. Genitourinary Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Ophthalmology
5.10.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Others
5.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Virtual Clinical Trials Market: Phase Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Virtual Clinical Trials Market: Phase Movement Analysis, USD Million, 2022 & 2030
6.3. Phase I
6.3.1. Phase I Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Phase II
6.4.1. Phase II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Phase III
6.5.1. Phase III Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Phase IV
6.6.1. Phase IV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Virtual Clinical Trials Market: Regional Estimates & Trend Analysis
7.1. Virtual Clinical Trials Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
7.2.1. North America Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Prevalence Insights
7.2.2.4. Regulatory Framework
7.2.2.5. Reimbursement Structure
7.2.2.6. U.S. Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Prevalence Insights
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Structure
7.2.3.6. Canada Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Prevalence Insights
7.3.2.4. Regulatory Framework
7.3.2.5. Reimbursement Structure
7.3.2.6. UK Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Prevalence Insights
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Structure
7.3.3.6. Germany Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Prevalence Insights
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Structure
7.3.4.6. France Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Prevalence Insights
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Structure
7.3.5.6. Italy Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Prevalence Insights
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Structure
7.3.6.6. Spain Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Prevalence Insights
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Structure
7.3.7.6. Denmark Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Prevalence Insights
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Structure
7.3.8.6. Sweden Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Prevalence Insights
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Structure
7.3.9.6. Norway Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Prevalence Insights
7.4.2.4. Regulatory Framework
7.4.2.5. Reimbursement Structure
7.4.2.6. Japan Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Prevalence Insights
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Structure
7.4.3.6. China Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Prevalence Insights
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Structure
7.4.4.6. India Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Prevalence Insights
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Structure
7.4.5.6. Australia Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Prevalence Insights
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Structure
7.4.6.6. Thailand Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Prevalence Insights
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Structure
7.4.7.6. South Korea Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Prevalence Insights
7.5.2.4. Regulatory Framework
7.5.2.5. Reimbursement Structure
7.5.2.6. Brazil Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Prevalence Insights
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Structure
7.5.3.6. Mexico Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Prevalence Insights
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Structure
7.5.4.6. Argentina Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Prevalence Insights
7.6.2.4. Regulatory Framework
7.6.2.5. Reimbursement Structure
7.6.2.6. South Africa Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Prevalence Insights
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Structure
7.6.3.6. Saudi Arabia Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Prevalence Insights
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Structure
7.6.4.6. UAE Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Prevalence Insights
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Structure
7.6.5.6. Kuwait Virtual Clinical Trials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Share Analysis, 2022
8.3. Strategy Mapping
8.4. Company Profiles/Listing
8.4.1. ICON, plc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. PAREXEL International Corporation
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. IQVIA
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Covance
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. PRA Health Sciences
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. LEO Innovation Lab
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Medidata
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Oracle
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. CRF Health
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Clinical Ink
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. Medable Inc.
8.4.11.1. Overview
8.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. Signant Health
8.4.12.1. Overview
8.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Halo Health Systems
8.4.13.1. Overview
8.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Croprime
8.4.14.1. Overview
8.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global Virtual Clinical Trials Market, By Region, 2018 - 2030 (USD Million)
Table 4. Global Virtual Clinical Trials Market, By Study Design, 2018 - 2030 (USD Million)
Table 5. Global Virtual Clinical Trials Market, By Indication, 2018 - 2030 (USD Million)
Table 6. Global Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 7. North America Virtual Clinical Trials Market, By Country, 2018 - 2030 (USD Million)
Table 8. North America Virtual Clinical Trials Market, By Study Design, 2018 - 2030 (USD Million)
Table 9. North America Virtual Clinical Trials Market, By Indication, 2018 - 2030 (USD Million)
Table 10. North America Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 11. U.S. Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 12. U.S. Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 13. U.S. Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 14. Canada Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 15. Canada Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 16. Canada Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 17. Europe Virtual Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18. Europe Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 19. Europe Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 20. Europe Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 21. UK Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 22. UK Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 23. UK Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 24. Germany Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 25. Germany Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 26. Germany Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 27. France Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 28. France Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 29. France Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 30. Italy Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 31. Italy Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 32. Italy Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 33. Spain Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 34. Spain Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 35. Spain Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 36. Denmark Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 37. Denmark Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 38. Denmark Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 39. Sweden Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 40. Sweden Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 41. Sweden Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 42. Norway Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 43. Norway Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 44. Norway Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 45. Asia Pacific Virtual Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 46. Asia Pacific Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 47. Asia Pacific Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 48. Asia Pacific Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 49. Japan Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 50. Japan Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 51. Japan Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 52. China Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 53. China Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 54. China Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 55. India Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 56. India Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 57. India Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 58. Australia Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 59. Australia Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 60. Austraila Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 61. Thailand Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 62. Thailand Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 63. Thailand Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 64. South Korea Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 65. South Korea Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 66. South Korea Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 67. Latin America Virtual Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 68. Latin America Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 69. Latin America Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 70. Latin America Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 71. Brazil Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 72. Brazil Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 73. Brazil Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 74. Mexico Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 75. Mexico Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 76. Mexico Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 77. Argentina Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 78. Argentina Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 79. Argentina Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 80. MEA Virtual Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 81. MEA Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 82. MEA Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 83. MEA Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 84. South Africa Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 85. South Africa Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 86. South Africa Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 89. Saudi Arabia Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 90. UAE Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 91. UAE Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 92. UAE Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 93. Kuwait Virtual Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 94. Kuwait Virtual Clinical Trials Market, by Indication, 2018 - 2030 (USD Million)
Table 95. Kuwait Virtual Clinical Trials Market, By Phase, 2018 - 2030 (USD Million)
Table 96. Participant’s overview
Table 97. Financial performance
Table 98. Key companies undergoing expansions
Table 99. Key companies undergoing acquisitions
Table 100. Key companies undergoing collaborations
Table 101. Key companies launching new products/services
Table 102. Key companies undergoing partnerships
Table 103. Key companies undertaking other strategies
List of Figures
Fig. 1 Market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation and validation
Fig. 9 Commodity flow analysis
Fig. 10 Virtual Clinical Trials Market Outlook, 2018 - 2030 (USD Million)
Fig. 11 Virtual Clinical Trials Market Summary, 2021 (USD Million)
Fig. 12 Market trends & outlook
Fig. 13 Parent Market Outlook
Fig. 14 Ancillary Market Outlook
Fig. 15 Market driver analysis (Current & future impact)
Fig. 16 Market restraint analysis (Current & future impact)
Fig. 17 Company market position analysis
Fig. 18 Virtual Clinical Trials market, study design outlook key takeaways (USD Million)
Fig. 19 Virtual Clinical Trials market: Study design movement analysis (USD Million)
Fig. 20 Interventional market, 2018 - 2030 (USD Million)
Fig. 21 Observational market, 2018 - 2030 (USD Million)
Fig. 22 Expanded access market, 2018 - 2030 (USD Million)
Fig. 23 Virtual clinical trials market indication outlook: Key takeaways
Fig. 24 Virtual clinical trials market: Indication movement analysis
Fig. 25 CNS market, 2018 - 2030 (USD Million)
Fig. 26 Autoimmune/inflammation market, 2018 - 2030 (USD Million)
Fig. 27 Cardiovascular disease market, 2018 - 2030 (USD Million)
Fig. 28 Metabolic/endocrinology market, 2018 - 2030 (USD Million)
Fig. 29 Infectious diseases market, 2018 - 2030 (USD Million)
Fig. 30 Oncology market, 2018 - 2030 (USD Million)
Fig. 31 Genitourinary market, 2018 - 2030 (USD Million)
Fig. 32 Ophthalmology market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Virtual Clinical Trials market, phase outlook key takeaways (USD Million)
Fig. 35 Virtual Clinical Trials market: Phase movement analysis (USD Million)
Fig. 36 Phase I market, 2018 - 2030 (USD Million)
Fig. 37 Phase II market, 2018 - 2030 (USD Million)
Fig. 38 Phase III market, 2018 - 2030 (USD Million)
Fig. 39 Phase IV market, 2018 - 2030 (USD Million)
Fig. 40 Regional outlook, 2018 & 2030
Fig. 41 Regional market dashboard
Fig. 42 Regional market place: Key takeaways
Fig. 43 North America virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 44 U.S. virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 45 Canada virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 46 Europe virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 47 UK virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 48 Germany virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 49 France virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 50 Italy virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 51 Spain virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 52 Denmark virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 53 Sweden virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 54 Norway virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 56 Japan virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 57 China (Mainland) virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 58 India virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 59 Australia virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 60 Thailand virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 61 South Korea virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 62 Latin America virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 63 Brazil virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 64 Mexico virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 65 Argentina virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 66 MEA virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 67 South Africa virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 68 Saudi Arabia virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 69 UAE virtual clinical trials market, 2018 - 2030 (USD Million)
Fig. 70 Kuwait virtual clinical trials market, 2018 - 2030 (USD Million)

Companies Mentioned

  • ICON, plc
  • PAREXEL International Corporation
  • IQVIA
  • Covance
  • PRA Health Sciences
  • LEO Innovation Lab
  • Medidata
  • Oracle
  • CRF Health
  • Clinical Ink
  • Medable Inc.
  • Signant Health
  • Halo Health Systems
  • Croprime

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages133
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 8.3 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.9 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Global Virtual Clinical Trials Market by Study Design (Expanded Access Trials, Interventional Trials, Observational Trials), Implication (Cardiovascular Disease, Oncology) - Forecast 2024-2030 - Product Image

Global Virtual Clinical Trials Market by Study Design (Expanded Access Trials, Interventional Trials, Observational Trials), Implication (Cardiovascular Disease, Oncology) - Forecast 2024-2030

  • Report
  • 182 Pages
  • Global
From
Global eClinical Solutions Market Size, Share & Trends Analysis Report by Product (Clinical Trial Management, Clinical Analytics Platforms), Delivery Mode (Web & Cloud Based, On-premise), Development Phase, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Global eClinical Solutions Market Size, Share & Trends Analysis Report by Product (Clinical Trial Management, Clinical Analytics Platforms), Delivery Mode (Web & Cloud Based, On-premise), Development Phase, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 200 Pages
  • Global
From
Virtual Clinical Trials Global Market Report 2024 - Product Image

Virtual Clinical Trials Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Virtual Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Virtual Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 172 Pages
  • Global
From
Global Virtual Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Virtual Clinical Trials - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 125 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.